Travere Therapeutics (TVTX) Q2 2024 Earnings

6MayConfirmed
Q2 2023
Q3 2023
Q4 2023
Q2 2024
-1.76
-0.42
0.93
2.27

Details

Expected EPS
-0.940003
Actual EPS
-1.76
Surprise EPS
-0.82
Surprise Percent
+87.23%

Description

Travere Therapeutics (TVTX) has reported earnings of -1.76 per share for Q2 2024.

0 Comments

Share your thoughts